Charles River Associates (CRAI)
(Delayed Data from NSDQ)
$163.48 USD
+3.06 (1.91%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $162.92 -0.56 (-0.34%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$163.48 USD
+3.06 (1.91%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $162.92 -0.56 (-0.34%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth A Momentum B VGM
Zacks News
Reasons Why You Should Bet on Charles River (CRAI) Stock Now
by Zacks Equity Research
Commitment to shareholder returns makes Charles River (CRAI) a reliable way for investors to compound wealth over the long term.
CRA (CRAI) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
CRA (CRAI) possesses solid growth attributes, which could help it handily outperform the market.
Is ABM Industries (ABM) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how ABM Industries (ABM) and CRA International (CRAI) have performed compared to their sector so far this year.
Zacks.com featured highlights Leidos, Trane, Cabot, Vertiv and Charles River
by Zacks Equity Research
Leidos, Trane, Cabot, Vertiv and Charles River have been highlighted in this Screen of The Week article.
Acquisitions Aid Waste Connections (WCN) Amid Low Liquidity
by Zacks Equity Research
Waste Connections (WCN) gains from a decentralized operational structure and acquisitions.
5 Dividend Growth Stocks to Boost Your Portfolio
by Sweta Killa
Leidos Holdings (LDOS), Trane Technologies (TT), Cabot Corporation (CBT), Vertiv Holdings (VRT) and Charles River (CRAI) could be solid choices for your portfolio.
Here's Why You Should Retain Accenture (ACN) Stock for Now
by Zacks Equity Research
Accenture's (ACN) disciplined acquisition strategy focuses on channeling its business in high-growth areas, adding skills and capabilities, and deepening industry and functional expertise.
Here's Why You Should Retain IQVIA (IQV) Stock for Now
by Zacks Equity Research
IQVIA (IQV) rides high on robust segmental performance, boosting the company's top line. However, elevated operating expenses and weak liquidity are a major concern.
Best Growth Stocks to Buy for August 15th
by Zacks Equity Research
BLBD, CRAI and PPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 15, 2024.
Best Growth Stocks to Buy for August 13th
by Zacks Equity Research
BLBD, CRAI and PPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 13, 2024.
CRA International (CRAI) Shares Rise 2% Since Q2 Earnings Beat
by Zacks Equity Research
CRA International's (CRAI) second-quarter 2024 earnings and revenues increase year over year.
3 Reasons Growth Investors Will Love CRA (CRAI)
by Zacks Equity Research
CRA (CRAI) possesses solid growth attributes, which could help it handily outperform the market.
What Makes CRA (CRAI) a New Strong Buy Stock
by Zacks Equity Research
CRA (CRAI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Charles River Associates (CRAI) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how CRA International (CRAI) and ABM Industries (ABM) have performed compared to their sector so far this year.
CRA International (CRAI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CRA (CRAI) delivered earnings and revenue surprises of 22.82% and 2.13%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Rank Explained: How to Find Strong Buy Business Services Stocks
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Charles River (CRAI) Stock Rises 76% Year to Date: Here's How
by Zacks Equity Research
Charles River (CRAI) has a consistent track record of rewarding shareholders through dividends and share repurchases.
Republic Services (RSG) Stock Gains 32% in a Year: Here's Why
by Zacks Equity Research
Republic Services (RSG) gains from increasing environmental concerns, rapid industrialization and government measures to reduce illegal dumping.
CRAI or IT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRAI vs. IT: Which Stock Is the Better Value Option?
Is Charles River Associates (CRAI) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how CRA International (CRAI) and SPX Technologies (SPXC) have performed compared to their sector so far this year.
CRAI vs. IT: Which Stock Is the Better Value Option?
by Zacks Equity Research
CRAI vs. IT: Which Stock Is the Better Value Option?
Growing PEO Industry Aids Insperity (NSP) Despite Rising Costs
by Zacks Equity Research
Insperity's (NSP) rise in worksite employees is a result of its strong sales performance and improved client retention rates.
CRAI vs. IT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CRAI vs. IT: Which Stock Is the Better Value Option?
Paychex (PAYX) Q4 Earnings Beat on Segmental Performance
by Zacks Equity Research
Paychex's (PAYX) fourth-quarter fiscal 2024 results benefit from an increase in the number of clients served across the HCM solutions and lower losses on investment sales in portfolio repositioning.
Clinical Development Expertise Aids IQVIA (IQV), Costs High
by Zacks Equity Research
IQVIA (IQV) benefits from its healthcare-specific global IT infrastructure and domain expertise to expand and penetrate different markets.